Picture of Nkarta logo

NKTX Nkarta Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual income statement for Nkarta, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS/A10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.1150000
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses23.251.586.4119132
Operating Profit-23.1-51.5-86.4-119-132
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-21.1-91.4-86.1-114-118
Net Income After Taxes-21.1-91.4-86.1-114-118
Net Income Before Extraordinary Items
Net Income-21.1-91.4-86.1-114-118
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-21.1-91.4-86.1-114-118
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.668-2.8-2.62-2.61-2.31
Dividends per Share